almee

virtual med

First Patient Enrolled in New Digital Therapy Study for IPF

A new clinical study assessing the effect of digital cognitive behavioral therapy in patients with idiopathic pulmonary fibrosis (IPF) enrolled its first participant in its US pilot phase.  The study called COMPANION is sponsored by Vicore Pharma and is a fully digitalized, randomized, controlled parallel-group trial that aims to evaluate the impact of the digital…

Next post in IPF News Briefs